Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

18.18 USD -0.27 (-1.46%)
Streaming Delayed Price Updated: 10:53 AM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 95,491
Open 18.28
Bid (Size) 18.18 (1)
Ask (Size) 18.22 (1)
Prev. Close 18.45
Today's Range 18.11 - 18.56
52wk Range 8.670 - 20.29
Shares Outstanding 38,280,637
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lantheus Announces Publication of PyL™ (18F-DCFPyL) Results from Pivotal Studies
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to... 
From Business Wire News Releases
Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to... 
From Business Wire News Releases

Performance

YTD
+32.03%
+32.03%
1 Month
+7.38%
+7.38%
3 Month
+34.77%
+34.77%
6 Month
+35.27%
+35.27%
1 Year
+17.75%
+17.75%

More News

Read More
Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference
From Business Wire News Releases
Lantheus Holdings to Host Fourth Quarter and Full Year 2020 Earnings Conference Call and Webcast on February 25, 2020 at 4:30 p.m. Eastern Time
From Business Wire News Releases
Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting
From Business Wire News Releases
Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.
From Business Wire News Releases
Sum Up The Parts: PSCH Could Be Worth $202
Tags ETFs
From ETF Channel
Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent
From Business Wire News Releases
PyL™ (18F-DCFPyL), Lantheus’ PSMA-Targeted Prostate Cancer Imaging Agent, to be Used in POINT Biopharma’s PSMA-Targeted Radioligand Therapeutic Phase 3 Trial in Patients with Metastatic Castration Res
From Business Wire News Releases
Recap: Lantheus Holdings Q4 Earnings
Tags Benzinga LNTH Earnings
From Benzinga
Lantheus Holdings, Inc. Announces Agreement to Sell Its Puerto Rico Radiopharmacy and PET Manufacturing Facility and Enter into Long-Term Supply Agreement
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.